AU2003231571A1 - External preparation enhanced in systemic property of vidarabine - Google Patents

External preparation enhanced in systemic property of vidarabine

Info

Publication number
AU2003231571A1
AU2003231571A1 AU2003231571A AU2003231571A AU2003231571A1 AU 2003231571 A1 AU2003231571 A1 AU 2003231571A1 AU 2003231571 A AU2003231571 A AU 2003231571A AU 2003231571 A AU2003231571 A AU 2003231571A AU 2003231571 A1 AU2003231571 A1 AU 2003231571A1
Authority
AU
Australia
Prior art keywords
vidarabine
external preparation
systemic property
preparation enhanced
enhanced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003231571A
Other languages
English (en)
Inventor
Hirosato Fujii
Yumio Kudo
Motoo Yamagata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of AU2003231571A1 publication Critical patent/AU2003231571A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003231571A 2002-04-30 2003-04-30 External preparation enhanced in systemic property of vidarabine Abandoned AU2003231571A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-129138 2002-04-30
JP2002129138 2002-04-30
PCT/JP2003/005539 WO2003092704A1 (fr) 2002-04-30 2003-04-30 Preparation externe de vidarabine a propriete systemique amelioree

Publications (1)

Publication Number Publication Date
AU2003231571A1 true AU2003231571A1 (en) 2003-11-17

Family

ID=29397294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003231571A Abandoned AU2003231571A1 (en) 2002-04-30 2003-04-30 External preparation enhanced in systemic property of vidarabine

Country Status (2)

Country Link
AU (1) AU2003231571A1 (fr)
WO (1) WO2003092704A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
JPH09316001A (ja) * 1996-05-31 1997-12-09 Sekisui Chem Co Ltd ウイルス性皮膚疾患治療用外用剤
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
JPH11222443A (ja) * 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk 経皮吸収促進組成物および経皮吸収製剤
JP3571511B2 (ja) * 1997-11-11 2004-09-29 トーアエイヨー株式会社 経皮吸収製剤
JP2000281573A (ja) * 1999-03-26 2000-10-10 Toko Yakuhin Kogyo Kk 一硝酸イソソルビドを主薬とする経皮吸収性テープ剤
AU3536799A (en) * 1999-04-26 2000-11-10 Lead Chemical Co., Ltd. Percutaneous preparations containing oxybutynin
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
JP2002302433A (ja) * 2000-12-01 2002-10-18 Mochida Pharmaceut Co Ltd 低刺激性クリーム剤

Also Published As

Publication number Publication date
WO2003092704A1 (fr) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
AU2002318298A1 (en) Defining external parameters in spreadsheets
AU2003233069A1 (en) Gel and powder making
IL164463A0 (en) Use of osteoprotegerin in the preparation of medicaments
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2003252694A1 (en) External preparation
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2002355361A1 (en) Improvements in or relating to encapsulation
AU2003207824A1 (en) K-type polarizer and preparation thereof
AU2003206170A1 (en) Organic-inorganic nanocomposite and preparation thereof
AU2002308503A1 (en) Relationship to other applications and patents
AU2003212891A1 (en) K-type polarizer and preparation thereof
AU2003202791A1 (en) Improvements in or relating to wireless terminals
AU2003284460A1 (en) Medicinal composition
AU2003239689A1 (en) Improvements in and relating to the deployment of traffic cones
AU2003231571A1 (en) External preparation enhanced in systemic property of vidarabine
AU2002338509B2 (en) Improvements in and relating to the administration of copper to an animal
AU2003901205A0 (en) Therapeutic and prophylactic compositions and uses therefor
AU2003280799A1 (en) Medicinal composition
AU2003229769A1 (en) Multifunctional polyethylene glycol derivatives: preparation and use
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003240446A1 (en) Use of mob-5 in pain
AU2003271840A1 (en) Improvements to oxide films
AU2002338561A1 (en) Lipid producing cells and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase